Intrexon | XON - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Agenus USD 22.34M 107K 2026-03
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 10.23B 1.09B 2026-06
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 8.56M 7.13M 2026-06
AstraZeneca USD 18.86B 972M 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Gilead Sciences USD 5.06B 314M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Heron Therapeutics USD 89.59M 8.54M 2025-12
Incyte USD 1.13B 73.7M 2026-06
Intrexon USD 1.02M 559K 2024-06
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
MacroGenics USD 10.42M 2.95M 2026-03
MannKind USD 43.21M 15.07M 2026-06
Merck USD 12.21B 435M 2026-03
Novartis USD 9.85B 252M 2026-06
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sangamo BioSciences USD 581K 110K 2024-06
Thermo Fisher Scientific USD 9.45B 247M 2026-06
Veracyte USD 54.18M 4.06M 2026-06
Xencor USD 42.23M 30.23M 2026-06